Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14760643 | 1.00 | CA2 (0.38) | CA2 | |
| SCHEMBL4732017 | 1.00 | CA2 (0.38) | CA2 | |
| SCHEMBL1533866 | 0.92 | — | — | |
| SCHEMBL10308667 | 0.90 | CA2 (0.35) | CA2 | |
| SCHEMBL27637766 | 0.82 | — | — | |
| Cesium SCHEMBL8429146 | 0.80 | CA2 (0.42) | CA2 | |
| SCHEMBL178840 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL19619507 | 0.79 | CA2 (0.33) | CA2 | |
| SCHEMBL20034383 | 0.79 | ALDH1A1 (0.41) | — | |
| SCHEMBL3799045 | 0.79 | CYP3A4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11833495-B2 | Heterobimetallic catalysts and site-differentiated ligands for preparation thereof | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-12-05 | — | — | US | disclosed |
| US-11833495-B2 | Heterobimetallic catalysts and site-differentiated ligands for preparation thereof | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230249169-A1 | HETEROBIMETALLIC CATALYSTS AND SITE-DIFFERENTIATED LIGANDS FOR PREPARATION THEREOF | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-08-10 | — | — | US | disclosed |
| US-20230249169-A1 | HETEROBIMETALLIC CATALYSTS AND SITE-DIFFERENTIATED LIGANDS FOR PREPARATION THEREOF | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-08-10 | — | — | US | disclosed |
| US-11712686-B2 | Heterobimetallic catalysts and site-differentiated ligands for preparation thereof | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-08-01 | — | — | US | disclosed |
| US-11712686-B2 | Heterobimetallic catalysts and site-differentiated ligands for preparation thereof | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-08-01 | — | — | US | disclosed |
| CN-116462709-A | Phosphate group-containing compound, preparation method thereof and application thereof in perovskite light-emitting device | 中国科学院长春应用化学研究所 | 2023-07-21 | — | — | CN | disclosed |
| US-8337788-B2 | Method for preparing a colloidal zirconia solution | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2012-12-25 | — | — | US | disclosed |
| US-20100144918-A1 | Method for Preparing a Colloidal Zirconia Solution | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE (FR) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144918-A1 | Method for Preparing a Colloidal Zirconia Solution | ZRANB2, NPM1, NAF1 | CA2 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.